PFRree
Latest News
Contact us
Send a Release
Login
Create Free Account
Login
Create Free Account
Cellpointweb
·
Newsroom
CellPoint Plans to Complete Phase 2b Trial in Evaluating the Presence and Severity of Coronary Artery Disease
CellPoint is a biopharmaceutical company focused on the development of universal molecular imaging compounds and molecular therapeutics for the diagnosis, staging, treatment.
May 20, 2019
©2010-2023 PRFREE.ORG